1-10324381-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001365951.3(KIF1B):​c.2537+319A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.241 in 152,110 control chromosomes in the GnomAD database, including 5,129 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 5129 hom., cov: 32)

Consequence

KIF1B
NM_001365951.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.421

Publications

5 publications found
Variant links:
Genes affected
KIF1B (HGNC:16636): (kinesin family member 1B) Predicted to enable microtubule binding activity and plus-end-directed microtubule motor activity. Predicted to be involved in chemical synaptic transmission; dense core granule cytoskeletal transport; and vesicle-mediated transport. Predicted to act upstream of or within mitochondrion transport along microtubule. Predicted to be located in cytoplasmic vesicle membrane and neuron projection. Predicted to be part of kinesin complex. Predicted to be active in several cellular components, including axon; dendrite; and microtubule. Implicated in Charcot-Marie-Tooth disease type 2A1; carcinoma (multiple); multiple sclerosis; neuroblastoma; and pheochromocytoma. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
KIF1B Gene-Disease associations (from GenCC):
  • pheochromocytoma
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease type 2A1
    Inheritance: AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neuroblastoma, susceptibility to, 1
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.306 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365951.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF1B
NM_001365951.3
MANE Select
c.2537+319A>G
intron
N/ANP_001352880.1
KIF1B
NM_001365952.1
c.2537+319A>G
intron
N/ANP_001352881.1
KIF1B
NM_015074.3
c.2399+319A>G
intron
N/ANP_055889.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF1B
ENST00000676179.1
MANE Select
c.2537+319A>G
intron
N/AENSP00000502065.1
KIF1B
ENST00000377081.5
TSL:1
c.2537+319A>G
intron
N/AENSP00000366284.1
KIF1B
ENST00000377086.5
TSL:1
c.2537+319A>G
intron
N/AENSP00000366290.1

Frequencies

GnomAD3 genomes
AF:
0.241
AC:
36573
AN:
151992
Hom.:
5116
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0932
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.312
Gnomad ASJ
AF:
0.266
Gnomad EAS
AF:
0.284
Gnomad SAS
AF:
0.250
Gnomad FIN
AF:
0.295
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.298
Gnomad OTH
AF:
0.256
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.241
AC:
36609
AN:
152110
Hom.:
5129
Cov.:
32
AF XY:
0.242
AC XY:
17982
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.0933
AC:
3875
AN:
41542
American (AMR)
AF:
0.313
AC:
4781
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.266
AC:
925
AN:
3472
East Asian (EAS)
AF:
0.283
AC:
1469
AN:
5182
South Asian (SAS)
AF:
0.250
AC:
1207
AN:
4822
European-Finnish (FIN)
AF:
0.295
AC:
3112
AN:
10542
Middle Eastern (MID)
AF:
0.211
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
0.298
AC:
20233
AN:
67956
Other (OTH)
AF:
0.260
AC:
549
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1363
2725
4088
5450
6813
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
372
744
1116
1488
1860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.250
Hom.:
913
Bravo
AF:
0.238
Asia WGS
AF:
0.275
AC:
954
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.6
DANN
Benign
0.54
PhyloP100
0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17401924; hg19: chr1-10384439; API